For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (425) 365-2933 (Registrant's telephone number, including area code) For the transition period from _________to __________ Commission File Number 001-41361 AIMFINITY INVESTMENT CORP. I (Exact name of registrant ...

Wilmington, DE, April 30, 2025 (GLOBE NEWSWIRE) -- Aimfinity Investment Corp. I (the “AIMA”) (Nasdaq: AIMAU), a special purpose acquisition company, today announced that, as anticipated, AIMA received a notice from The Nasdaq Stock Market LLC (“Nasdaq” or the “Exchange”), stating that in accordance with Nasdaq rules, its securities will be delisted from the Exchange. At the open of trading on Monday, May 5, 2025, AIMA’s securities will be suspended on Nasdaq and are expected to begin trading on the OTC Mark ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 For the transition period from __________ to __________. Commission File Number: 001-41361 FORM 10-K AIMFINITY INVESTMENT CORP. I (Mark One) (Exact name of registrant as specified in its charter) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (425) 365-2933 (Reg ...

Core Viewpoint - Aimfinity Investment Corp. I (AIMA) has successfully approved its business combination with Docter Inc., a Taiwanese health technology company, with approximately 93.8% of votes in favor at the extraordinary general meeting of shareholders [1] Group 1: Business Combination Details - The business combination between AIMA and Docter was approved on March 27, 2025, at an extraordinary general meeting [1] - AIMA has extended the deadline for completing the business combination from March 28, 2025, to April 28, 2025, by depositing $55,823.80 into its trust account, equating to $0.05 per Class A ordinary share held by public shareholders [2] - AIMA's current charter allows for monthly extensions of the business combination deadline until October 28, 2025, with this being the third of nine available extensions [3] Group 2: Company Profiles - Aimfinity Investment Corp. I is a special purpose acquisition company (SPAC) focused on merging with high-growth potential businesses to facilitate their entry into capital markets [4] - Docter Inc. is a leading health technology company that develops innovative health monitoring solutions aimed at enhancing the accessibility and efficiency of global healthcare services [5] Group 3: Regulatory and Procedural Information - AIMA entered into a merger agreement with Docter on October 13, 2023, which involves a reincorporation merger and an acquisition merger [6] - AIMA has filed a final prospectus with the SEC on March 6, 2025, detailing the proposed transactions, and proxy materials have been mailed to shareholders [11]

Company Overview - Aimfinity Investment Corp. I is a special purpose acquisition company (SPAC) incorporated in the Cayman Islands, focused on effecting mergers, share exchanges, asset acquisitions, and similar business combinations with various businesses or entities [3] - The company has not yet selected a business combination target and has not initiated substantive discussions with any potential targets [3] - Aimfinity will not complete its initial business combination with any target headquartered in China or conducting a majority of its business in China [3] Business Combination Update - The company announced an extension of the deadline to complete its initial business combination from February 28, 2025, to March 28, 2025, with a Monthly Extension Payment of $55,823.8, equating to $0.05 per Class A ordinary share held by public shareholders [1][2] - This extension is the second of nine monthly extensions allowed under the company's current charter, which permits monthly extensions from January 28, 2025, until October 28, 2025 [2] Merger Agreement - On October 13, 2023, Aimfinity entered into a Merger Agreement with Docter Inc., proposing a business combination involving a reincorporation merger and an acquisition merger [4] - The press release indicates that further information regarding the proposed business combination will be provided in a proxy statement/prospectus to be mailed to stockholders [4]

Company Overview - Aimfinity Investment Corp. I is a special purpose acquisition company (SPAC) incorporated in the Cayman Islands, aiming to effect a merger, share exchange, asset acquisition, or similar business combination with one or more businesses or entities [3] - The company has not yet selected a business combination target and has not initiated substantive discussions with any potential targets [3] - Aimfinity will not complete its initial business combination with a target headquartered in China or conducting a majority of its business in China [3] Business Combination Extension - The company announced an extension of the deadline to complete its initial business combination from January 28, 2025, to February 28, 2025, by depositing $55,823.8 into its trust account, equating to $0.05 per Class A ordinary share held by public shareholders [1] - This extension is the first of nine monthly extensions allowed under the company's current charter, which permits extensions until October 28, 2025 [2] Proposed Merger - On October 13, 2023, Aimfinity entered into a Merger Agreement with Docter Inc., proposing a business combination involving a reincorporation merger and an acquisition merger [4] - The press release indicates that further details regarding the proposed business combination will be provided in a proxy statement/prospectus to be filed with the SEC [4]

Core Points - Aimfinity Investment Corp. I held an Extraordinary General Meeting on January 9, 2025, to address matters typically discussed in an annual general meeting [1] - Shareholders approved an amendment to the Company's Charter, allowing an extension for the initial business combination until January 28, 2025, with the possibility of extending it up to nine additional months, totaling a potential deadline of October 28, 2025 [2][4] - The Company will require a Monthly Extension Payment of $0.05 for each public share for each one-month extension [2][4] - Mr. Kevin D. Vassily was re-elected as an independent director for a three-year term, and MaloneBailey, LLP was ratified as the independent registered public accounting firm for fiscal years 2023 and 2024 [3] Company Overview - Aimfinity Investment Corp. I is a blank check company incorporated in the Cayman Islands, focused on mergers, share exchanges, asset acquisitions, and similar business combinations [5] - The Company has not yet selected a business combination target and has not initiated substantive discussions with any potential targets [5] - Aimfinity Investment Corp. I will not complete a business combination with any target headquartered in China or conducting a majority of its business in China [5] Proposed Business Combination - On October 13, 2023, the Company entered into a Merger Agreement with Docter Inc., proposing a business combination involving a reincorporation merger and an acquisition merger [6]

Core Viewpoint - Aimfinity Investment Corp. I has announced revised terms for its Charter Amendment Proposal in connection with an extraordinary general meeting of shareholders, which has been adjourned to January 9, 2025 [1][2]. Group 1: Meeting Details - The deadline for public shareholders to submit redemption requests has been extended to 5:00 p.m. Eastern Time on January 8, 2025 [3]. - The record date for determining shareholders entitled to vote at the meeting remains November 27, 2024, allowing shareholders who sold their shares after this date to still vote [3]. - The physical location of the extraordinary meeting is confirmed to be in Pingtung City, Taiwan, with virtual attendance available through prior registration [4]. Group 2: Charter Amendment Proposal - If approved, the Company will have until January 28, 2025, to complete a business combination, with the option to extend this deadline up to nine times, each by one month, potentially extending to October 28, 2025 [6]. - The new required contribution to the trust account for each New Monthly Extension is set at $0.05 per remaining public share, compared to the original proposal of $0.033 per share or a total of $15,000 for all remaining shares [6]. - The Company has agreed not to use trust proceeds, including interest earned, to pay for dissolution expenses [6]. Group 3: Proxy and Documentation - A proxy statement was filed with the SEC on December 11, 2024, urging investors to read it carefully for important information regarding the meeting [8]. - Free copies of the proxy statement and other documents can be obtained through the SEC's website or by contacting the proxy solicitor [9].

Company Overview - Aimfinity Investment Corp. I (AIMA) is a special purpose acquisition company incorporated as a Cayman Islands exempted company, focused on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities [14] Proposed Business Combination - On October 13, 2023, AIMA entered into a Merger Agreement with Docter Inc. and its subsidiaries, proposing a business combination involving a reincorporation merger and an acquisition merger [2] - The proposed business combination is subject to the approval of AIMA's stockholders, who will receive a proxy statement/prospectus with important information regarding the transaction [2][8] Extension of Business Combination Deadline - AIMA has extended the deadline to complete its initial business combination from December 28, 2024, to January 28, 2025, by depositing $60,000 into its trust account [13] Future Financial Performance - The press release includes forward-looking statements regarding anticipated future financial and operating performance, including estimates for growth and expected management and governance of the combined company [9][15]

Company Overview - Aimfinity Investment Corp. I is a special purpose acquisition company incorporated in the Cayman Islands, focused on effecting mergers, share exchanges, asset acquisitions, and similar business combinations with various businesses or entities [3] - The company has not yet selected a business combination target and has not initiated substantive discussions with any potential targets [3] - Aimfinity will not complete its initial business combination with a target headquartered in China or conducting a majority of its business in China [3] Business Combination Update - The company announced an extension of the deadline to complete its initial business combination from November 28, 2024, to December 28, 2024, following a deposit of $60,000 into its trust account [1] - This extension marks the eighth of nine monthly extensions allowed under the company's current charter, which permits monthly extensions until January 28, 2025 [2] Merger Agreement - On October 13, 2023, Aimfinity entered into a Merger Agreement with Docter Inc., proposing a business combination involving a reincorporation merger and an acquisition merger [4] - The press release indicates that further details regarding the proposed business combination will be provided in a proxy statement/prospectus to be filed with the SEC [4]